Authors : Archana Mani; Saradhai Pandurangan; Dr. Sasikala Shanmugam

Volume/Issue : Volume 10 - 2025, Issue 11 - November

Google Scholar : https://tinyurl.com/3cznhb35

Scribd : https://tinyurl.com/332tkrav

DOI : https://doi.org/10.38124/ijisrt/25nov289

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Introduction: The emergence of Extended Spectrum Beta-Lactamases (ESBLs), AmpC β-lactamases and their co-existence among the members of Enterobacteriaceae has been found to be alarmingly high and poses newer diagnostic and treatment challenges.  Materials and Methods: In this study, we investigated both ESBL and AmpC β-lactamases in clinical isolates of Klebsiella pneumoniae (64). The detection of ESBL and AmpC β-lactamases was performed based on screening and confirmatory tests. The isolates that screened positives were phenotypically confirmed by the double disc synergy test and the Cefoxitin-Cloxacillin Double disk synergy test. Conventional PCR was performed to screen for the presence of ESBL-encoding gene blaTEM and the AmpC- encoding gene blaMOX.  Result: The most common method used was DDST, which detected 50% of ESBL producers, followed closely by ESBL screening at 42.19%. Cefoxitin screening and the Cefoxitin-Cloxacillin Double Disk Synergy Test each accounted for 12.5% of the cases. ESBL gene was detected in 29 (46.7%) isolates. None of the isolates showed positive for blaMOX genes.  Conclusion: The Cefoxitin resistance was found to be a discriminative parameter in detecting the AmpC-producing strains. The high positive rate of ESBLs and AmpC beta-lactamases production in isolates calls for the need for strong intervention to minimize further occurrence and spread of such resistance.

Keywords : Klebsiella Pneumoniae, ESBL, AmpC, Drug Resistance.

References :

1. Salvia, T., et al. (2022). Phenotypic Detection of ESBL, AmpC, MBL, and Their Cooccurrence among MDR Enterobacteriaceae Isolates in a Tertiary Care Hospital in Sikkim, India. Journal of Laboratory Physicians. https://doi.org/10.1055/s-0042-1744239
2. Gupta, G., Tak, V., &Mathur, P. (2014). Detection of AmpC β Lactamases in Gram negative Bacteria. Journal of Laboratory Physicians, 6(1), 1–6. https://doi.org/10.4103/0974-2727.129082
3. Gupta, T. B., et al. (2017). Identification of AmpC β-lactamase-producing clinical isolates of Escherichia coli. Asian Journal of Pharmaceutical and Clinical Research, 10(12), 357. https://doi.org/10.22159/ajpcr.2017.v10i12.21648
4. Maraskolhe, D. L., et al. (2014). Comparison of three Laboratory Tests for Detection of Ampc ß Lactamases in Klebsiella Species and E. Coli. Journal of Clinical and Diagnostic Research. https://doi.org/10.7860/jcdr/2014/8256.4432
5. Mohamudha, P. R., et al. (2010). AmpC beta lactamases among Gram negative clinical isolates from a tertiary hospital, South India. Brazilian Journal of Microbiology, 41(3), 596–602. https://doi.org/10.1590/s1517-83822010000300009
6. Gupta, Varsha; Kumarasamy, Karthikeyan^*; Gulati, Neelam; Garg, Ritu; Krishnan, Padma^*; Chander, Jagdish. AmpC β-lactamases in nosocomial isolates of Klebsiella pneumoniae from India. The Indian Journal of Medical Research 136(2):p 237-241, August 2012.
7. Kazi, M., et al. (2019). Multiplex PCR to detect pAmpC β-lactamases among enterobacteriaceae at a tertiary care laboratory in Mumbai, India. Microbiology, 165(2), 246–250. https://doi.org/10.1099/mic.0.000748
8. Soha A. El-Hady, Lamiaa A. Adel, Occurrence and detection of AmpC β-lactamases among Enterobacteriaceae isolates from patients at Ain Shams University Hospital, Egyptian Journal of Medical Human Genetics, Volume 16, Issue 3,2015, https://doi.org/10.1016/j.ejmhg.2015.03.001.
9. CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 34^th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2024.
10. M. José Gude, et al. (2012). Evaluation of four phenotypic methods to detect plasmid mediated AmpC β-lactamases in clinical isolates. European Journal of Clinical Microbiology & Infectious Diseases, 31(8), 2037–2043. https://doi.org/10.1007/s10096- 011-1537-y
11. Zorgani A, Daw H, Sufya N, Bashein A, Elahmer O, Chouchani C. Co-Occurrence of Plasmid-Mediated AmpC β-Lactamase Activity Among Klebsiella pneumoniae and Escherichia Coli. The Open Microbiology Journal. 2017 Sep 26;11(1):195–202.  https://doi.org/10.2174/1874285801711010195
12. Verma, S., Kalyan, R. K., Gupta, P., Khan, M. D., & Venkatesh, V. (2022). Molecular Characterization of Extended-Spectrum β-Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolates and Their Antibiotic Resistance Profile in Health Care-Associated Urinary Tract Infections in North India. Journal of Laboratory Physicians, 15(02), 194–201. https://doi.org/10.1055/s-0042-1757416
13. Gajamer, V. R., et al. (2019). High prevalence of carbapenamase genes, AmpC genes and aminoglycoside resistance genes in extended spectrum β-lactamase positive uropathogens from Northern India. Journal of Global Antimicrobial Resistance. https://doi.org/10.1016/j.jgar.2019.07.029
14. Gill MK, Gill AK, Khanna A. Antibiogram of Klebsiella pneumoniae isolated from various clinical samples of hospitalized patients in a tertiary care hospital of North India. Trop J Pathol Microbiol. 2019;5(8):512- 516.
15. Tekele, S. G., et al. (2020). Extended-spectrum Beta-lactamase and AmpC beta lactamases producing gram-negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia. PLOS ONE, 15(11), e0241984. https://doi.org/10.1371/journal.pone.0241984
16. Arumugam K, Karande GS, Patil SR. Prevalence of Extended Spectrum b-lactamase and AmpC b-lactamase among Escherichia coli and Klebsiella pneumoniae in Urinary Tract Infections. J Pure Appl Microbiol. 2025;19(3):2237-2246. doi: 10.22207/JPAM.19.3.51
17. Bora, Arijit¹; Hazarika, Naba Kumar²; Shukla, Sanket Kumar³; Prasad, Kashi N.³; Sarma, Jayanta Biswa⁴; Ahmed, Giasuddin¹. Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian Journal of Pathology and Microbiology 57(2):p 249-254, Apr–Jun 2014. | DOI: 10.4103/0377-4929.134698
18. Sah, R. K., Dahal, P., Parajuli, R., Giri, G. R., & Tuladhar, E. (2024). Prevalence of blaCTX-M and blaTEM Genes in Cefotaxime-Resistant Escherichia coli Recovered from Tertiary Care at Central Nepal: A Descriptive Cross-Sectional Study. Canadian Journal of Infectious Diseases and Medical Microbiology, 2024, 1–10. https://doi.org/10.1155/2024/5517662
19. Mohamed, E. S., et al. (2020). Prevalence and molecular characteristics of ESBL and AmpC β-lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrobial Resistance & Infection Control, 9(1). https://doi.org/10.1186/s13756-020-00856-w
20. Mohammad Hossein Haddadi, Saeed Khoshnood, Maryam Koupaei, Mohsen Heidary, Melika Moradi, Ali Jamshidi, Hamid Behrouj, Ahmad Movahedpour, Mohammad Hassan Maleki, Roya Ghanavati, Evaluating the incidence of ampC-β-lactamase genes, biofilm formation, and antibiotic resistance among hypervirulent and classical Klebsiella pneumoniae strains, Journal of Applied Microbiology, Volume 134, Issue 11, November 2023, lxad241, https://doi.org/10.1093/jambio/lxad241
21. Inamdar, D. P., &Anuradha B. (2020). Phenotypic methods for detection of Amp C b lactamases in Gram negative clinical isolates of a tertiary care hospital. Indian Journal of Microbiology Research, 7(2), 125–129. https://doi.org/10.18231/j.ijmr.2020.024
22. Zhijun Zhu* , Ying Lu* , Xinzhi Mao, Mei Zhu, The prevalence and distribution characteristics of beta-lactamase resistant genes and virulence factors in Klebsiella pneumoniae, Int J Clin Exp Med 2021;14(8):2189-2200
23. El-Hady, S. A., et al. (2015). Occurrence and detection of AmpC β-lactamases among Enterobacteriaceae isolates from patients at Ain Shams University Hospital. Egyptian 42 Journal of Medical Human Genetics, 16(3), 239–244. https://doi.org/10.1016/j.ejmhg.2015.03.001